Active Ingredient(s): Almotriptan
FDA Approved: * May 7, 2001
Category: Migraine / Tension Headache

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Axert Overview

Almotriptan (trade name Axert and others) is a triptan drug discovered and developed by Almirall for the treatment of heavy migraine headache. It was patented in 1992 and approved for medical use in 2000.[1] Contents 1 Medical uses 1.1 Efficacy 2 Contraindications 3 Side effects 4 Pharmacology 4.1 Mechanism of action 4.2 Pharmacokinetics 5 Interactions 6 Society and culture 6.1 Brand names 7 References 8 External links Medical uses Almotriptan is prescribed to...

Read more Axert Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Axert Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 12.5mg, 6.25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Axert: (5 results)

Sorted by National Drug Code
  • 0062-2080 Axert 6.25 mg Oral Tablet by Ortho-mcneil-janssen Pharmaceuticals, Inc.
  • 0062-2085 Axert 12.5 mg Oral Tablet by Ortho-mcneil-janssen Pharmaceuticals, Inc.
  • 50458-210 Axert 12.5 mg Oral Tablet by Janssen Pharmaceuticals, Inc.
  • 50458-211 Axert 6.25 mg Oral Tablet by Janssen Pharmaceuticals, Inc.
  • 54868-5527 Axert 12.5 mg Oral Tablet by Physicians Total Care, Inc.

Other drugs which contain Almotriptan or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA